Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 27 Nov 2021 |
10 | Annexure -1 under rule 46 | 12 Apr 2024 |
11 | Order | 06 Jun 2024 |
12 | Certificate | 07 Jun 2024 |
2 | Reply to Exam Report (MIS-R) | 01 Mar 2022 |
3 | Journal Copy | 16 Jul 2022 |
4 | Journal Copy | 16 Jul 2022 |
5 | TM-O(NOTICE OF OPPOSITION) | 15 Sep 2022 |
6 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 04 Dec 2023 |
7 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 15 Feb 2024 |
8 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 16 Feb 2024 |
9 | Evidence Affidavit Under Rule 46 (TOP) | 12 Apr 2024 |
1 | Opposition Notice | 15020534 | 5906133 | 27 Mar 2023 |
2 | Hearing Notice | 16441922 | 6321005 | 03 Nov 2023 |
3 | Opposition Counter Statement | 16796670 | 6385679 | 12 Dec 2023 |
The application for Emidol was made on 27 November 2021.
The trademark applicant for Emidol is EMCURE PHARMACEUTICALS.
Emidol is applied in class(es) 41.
Application for Emidol is on Registered stage.
Application Id allotted to Emidol is 5225536.
Trademark agent or attorney for the application is Aditya & Associates.
Emidol filed with the Intellectual property office as a DEVICE.